Winton Group’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Sell
17,060
-19,140
-53% -$302K 0.01% 885
2026
Q1
$519K Buy
+36,200
New +$601K 0.02% 701
2025
Q3
– Sell
-22,368
Closed -$249K – 1000
2025
Q2
$249K Sell
22,368
-19,644
-47% -$230K 0.01% 720
2025
Q1
$490K Buy
42,012
+17,963
+75% +$231K 0.03% 508
2024
Q4
$329K Buy
+24,049
New +$349K 0.02% 507
2024
Q3
– Sell
-22,106
Closed -$262K – 755
2024
Q2
$262K Sell
22,106
-41,452
-65% -$473K 0.02% 508
2024
Q1
$763K Buy
+63,558
New +$946K 0.05% 396
2023
Q1
– Sell
-36,766
Closed -$306K – 1055
2022
Q4
$306K Buy
36,766
+2,144
+6% +$16K 0.02% 782
2022
Q3
$236K Buy
+34,622
New +$576K 0.02% 853

Other funds holding SHC

Winton Group's SHC Position: Q2 2026 in Review

Winton Group reduced its Sotera Health (SHC) stake by 53% in Q2 2026, selling an estimated $302K and leaving 17,060 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #885.

Winton Group first reported a position in SHC in Q3 2022 and has held it in 9 quarters since. The position peaked at $763K in Q1 2024. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Winton Group held 17,060 shares of Sotera Health worth $303K as of Q2 2026.
  • Winton Group sold 19,140 Sotera Health shares in Q2 2026, an estimated $302K.
  • Sotera Health made up 0.01% of Winton Group's portfolio in Q2 2026, its #885 holding.
  • Winton Group first reported a position in Sotera Health in Q3 2022 and has held it in 9 quarters since.
  • Winton Group's Sotera Health position peaked at $763K in Q1 2024.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.